HSON Stock Earnings: Hudson Global Beats EPS, Beats Revenue for Q2 2024 HSON stock results show that Hudson Global beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
HSON Stock Earnings: Hudson Global Misses EPS, Misses Revenue for Q1 2024 HSON stock results show that Hudson Global missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
HSON Stock Earnings: Hudson Global Misses EPS, Misses Revenue for Q4 2023 HSON stock results show that Hudson Global missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Earnings Scheduled For March 14, 2024 Companies Reporting Before The Bell • Pharming (
NASDAQ:PHAR ) is projected to report earnings for its fourth quarter.
Insiders Buying NextEra Energy And 3 Other Stocks Although US stocks closed mixed on Friday, there were a few notable insider trades.
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday Gainers Opiant Pharmaceuticals, Inc. (
NASDAQ: OPNT ) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
